Diabetes mellitus (DM) is the strongest risk factor of significant inflammation or fibrosis in chronic hepatitis B (CHB) combined with non-alcoholic fatty liver disease (NAFLD) Li, J., Rui, F., Nguyen, B., Zhu, C., Qiu, Y., Ding, W., Zheng, Q., Zeng, Q., He, Z., Shi, J., Wu, C., Nguyen, M. ELSEVIER. 2023: S638-S639

View details for Web of Science ID 001037135102257